Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Marabelle

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 12, 2016
A tribute to the life and career of Holbrook KohrtA Marabelle, R Houot
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2018
How do immune checkpoint-targeted antibodies work? The need for improved pharmacokinetic evaluation in early phase studiesP A Ascierto, A Marabelle
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 8, 2019
Hyperprogression during immunotherapy: do we really want to know?S Champiat, B Besse, A Marabelle
La Revue De Medecine Interne|July 11, 2002
[A decisive examination]A Marabelle, O Marty, L Mallet
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 25, 2007
[From Ipex to foxp3: a new contribution of pediatrics to the understanding of the immune system]A Marabelle, M Meyer, F Demeocq, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2017
Intratumoral immunotherapy: using the tumor as the remedyA Marabelle, L Tselikas, T de Baere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 4, 2025
Breaking the link: IL-6 targeting to uncouple toxicity and efficacy in patients treated with immune checkpoint blockadeM Roulleaux Dugage, O Lambotte, X Mariette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2019
Immune checkpoint inhibitor-based combinations: is dose escalation mandatory for phase I trials?V Simmet, L Eberst, A Marabelle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2016
Biomarkers associated with checkpoint inhibitorsG Manson, J Norwood, A Marabelle, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2020
Stability of nivolumab in its original vials after opening and handing in normal saline bag for intravenous infusionG Le Guyader, V Vieillard, S Mouraud, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 12, 2016
A tribute to the life and career of Holbrook KohrtA Marabelle, R Houot
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2018
How do immune checkpoint-targeted antibodies work? The need for improved pharmacokinetic evaluation in early phase studiesP A Ascierto, A Marabelle
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 8, 2019
Hyperprogression during immunotherapy: do we really want to know?S Champiat, B Besse, A Marabelle
La Revue De Medecine Interne|July 11, 2002
[A decisive examination]A Marabelle, O Marty, L Mallet
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 25, 2007
[From Ipex to foxp3: a new contribution of pediatrics to the understanding of the immune system]A Marabelle, M Meyer, F Demeocq, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2017
Intratumoral immunotherapy: using the tumor as the remedyA Marabelle, L Tselikas, T de Baere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 4, 2025
Breaking the link: IL-6 targeting to uncouple toxicity and efficacy in patients treated with immune checkpoint blockadeM Roulleaux Dugage, O Lambotte, X Mariette, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2019
Immune checkpoint inhibitor-based combinations: is dose escalation mandatory for phase I trials?V Simmet, L Eberst, A Marabelle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2016
Biomarkers associated with checkpoint inhibitorsG Manson, J Norwood, A Marabelle, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2020
Stability of nivolumab in its original vials after opening and handing in normal saline bag for intravenous infusionG Le Guyader, V Vieillard, S Mouraud, et al.
Pageof 5